Malden, MA, United States of America

Mats Harald Holmqvist

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 9.1

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Maldeh, MA (US) (2010)
  • Malden, MA (US) (2012 - 2019)

Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mats Harald Holmqvist

Introduction

Mats Harald Holmqvist, an inventor based in Malden, Massachusetts, has made significant contributions to the field of biomedical innovations. With a total of four patents to his name, Holmqvist is recognized for his cutting-edge work in developing therapeutic agents aimed at combating cancer and addressing inflammation.

Latest Patents

Holmqvist's latest patents showcase his expertise in the realm of antibody development. One notable invention is titled "Podocalyxin and TRA-related antibody, methods of preparation and uses as an anti-cancer therapeutic agent." This invention involves a specific antibody or its antigen-binding fragment that includes a heavy chain and light chain, featuring distinct amino acid sequences critical for its function. Additionally, he has developed compounds aimed at inflammation and immune-related uses through another patent that focuses on compounds of a specific formula. These innovations highlight Holmqvist's commitment to advancing healthcare solutions.

Career Highlights

Throughout his career, Mats Holmqvist has been associated with esteemed organizations such as Synta Pharmaceuticals Corporation and Curemeta Therapeutics, LLC. His tenure at these companies has allowed him to translate innovative ideas into practical applications, ultimately benefiting patient care and treatment methodologies.

Collaborations

Collaboration has played a vital role in Holmqvist's journey as an inventor. He has worked alongside colleagues like Shoujun Chen and Jun Jiang, pooling their expertise to foster groundbreaking research and devise effective therapeutic strategies.

Conclusion

Mats Harald Holmqvist's work epitomizes the spirit of innovation in the biomedical sector. With his advancements in antibody technology and focused therapeutic agents, he continues to pave the way for promising treatments in medicine. His work inspires future inventors and underscores the importance of collaboration in the quest for innovative solutions to pressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…